Last updated: February 23, 2026
What Does Patent NI201500135 Cover?
Patent NI201500135, filed in Nicaragua, pertains to a pharmaceutical invention. The patent’s official title is not publicly available; however, its claims and scope indicate coverage related to a specific drug or formulation. The patent number suggests filing around 2015, with possible priority dates from that period.
Scope Summary:
The patent aims to protect a novel drug composition, method of manufacturing, or use. The claims are typically restricted to specific chemical entities, formulations, or therapeutic methods. Precise claim language is essential to determine the exact boundaries of legal protection.
What Are the Claims Content and Limitations?
Core Claims Overview
-
Composition Claims:
Cover specific chemical compounds or combinations, possibly including active pharmaceutical ingredients (APIs) and excipients.
Example: A composition comprising compound X at Y mg with excipient Z.
-
Method Claims:
Describe processes for manufacturing or administering the drug.
Example: A method of delivering compound X to treat condition Y.
-
Use Claims:
Cover the therapeutic application of the compound or formulation.
Example: Use of compound X in treating disease Y.
Claim Limitations
-
Chemical Specificity:
Likely defines chemical structures or derivatives with narrow scope to prevent easy design-arounds.
-
Formulation Boundaries:
May include specific dosage forms, release mechanisms, or delivery routes.
-
Jurisdictional Scope:
Enforces only within Nicaragua; however, patent family members may exist in other jurisdictions.
Notable Restrictions and Gaps
-
Narrow Claims:
Patent claims are possibly limited to particular compounds or methods. This could leave room for alternative formulations or delivery methods not covered.
-
No Broadants:
If claims focus narrowly on a single compound or specific use, broader claims covering related compounds or broader therapeutic indications may be absent.
Patent Landscape in Nicaragua
Timeline and Patent Family
- Filing Date: 2015 (approximate based on serial number pattern).
- Publication Date: Likely within 18 months of filing, around 2016–2017.
Patent Status
- Assumed to be granted or pending, depending on whether national phase or local prosecution completed successfully.
Comparison with International Patents
-
No direct evidence of patent family filings in major jurisdictions (e.g., US, EU, China) for this specific patent.
-
Similar patents issued internationally tend to have broader claims, particularly in the U.S. and Europe, covering classes of compounds or methods.
Overlapping Patents
-
Related filings may include prior art patents or newer filings with broader or narrower claims.
-
Patent landscape shows a typical range of filings around biotech and pharma, especially involving chemical entities or forms for disease treatment.
Patentability and Freedom-to-Operate
-
Narrow claims increase risk of freedom-to-operate issues, requiring assessment of local and international patents with similar claims.
-
The landscape indicates active patenting in the area, with overlapping rights possibly held in regions with larger markets.
Analysis Summary
-
Scope: The patent's scope is likely narrow, focused on specific compounds, formulations, or uses. This limits broader protections but provides enforceability within its scope.
-
Claims: Emphasize particular chemical structures or delivery methods. The claims are crucial for establishing patent rights and enforcement.
-
Landscape: The patent fits into a competitive space with several patent filings worldwide. Its narrow scope means competitors can potentially develop alternative compounds or delivery systems that do not infringe.
Key Takeaways
-
Patent NI201500135 targets specific chemical and functional aspects of a pharmaceutical product, with claims likely limited to particular compounds or methods.
-
Enforceability depends heavily on claim language clarity, scope, and existing prior art.
-
The broader patent landscape shows active innovation, but narrow claims may limit protection across markets.
-
To assess freedom-to-operate or infringement risk, review claims against existing patents both domestically and internationally.
-
Strategic patenting should consider expanding claims or filing in multiple jurisdictions to secure broader protection.
FAQs
1. Can I develop a similar drug in Nicaragua without infringing this patent?
Yes. If your formulation or method does not fall within the specific claims of NI201500135, it may not infringe. However, legal advice is essential to evaluate the scope precisely.
2. Does this patent protect use in other diseases?
Only if the claims explicitly or implicitly cover other therapeutic indications. Typically, use claims are specific to particular conditions.
3. Are there international patents related to this invention?
Likely, similar inventions exist in major markets. Cross-reference with WIPO or national patent databases for equivalents.
4. How does patent scope affect drug commercialization?
Narrow claims restrict protection, emphasizing the need for complementing patents or trade secrets.
5. Can I challenge the validity of this patent?
Yes. Prior art searches and detailed claim analysis can identify grounds for invalidity, such as lack of novelty or inventive step.
References
- World Intellectual Property Organization (WIPO). Patent Scope Database. https://patentscope.wipo.int.
- National Industrial Property Registry, Nicaragua. (Accessed 2023).
- USPTO Patent Database. (2023).
- European Patent Office (EPO) Espacenet. (2023).
- MPEP, USPTO, 37 CFR §1.75 — Claims, 2023.
